To provide the information your oncologist is not telling you or doesn't have the time to!
Colon cancer is the third most common cancer worldwide, affecting millions of individuals every year. Currently, the treatment paradigm for resected stage 2 and 3 colon cancer patients typically involves surgery followed by adjuvant chemotherapy to reduce the risk of cancer recurrence. However, the prognosis for these patients varies significantly, with some experiencing a complete …
Merkel cell carcinoma (MCC) is the unsung villain of the skin cancer world – rare, aggressive, and often flying under the radar. MCC is a neuroendocrine skin cancer that usually rears its ugly head as a firm, painless nodule on sun-exposed areas of the skin. Risk factors for this sneaky skin invader include advanced age, …
“How am I doing?”, asked one of my colorectal patients. Ten years ago, I first met John (name changed for privacy), a warm and spirited individual diagnosed with stage 3 colon cancer. After undergoing surgical resection of the primary colon tumor and six months of standard adjuvant chemotherapy with mFOLFOX, John and I optimistically looked …
New and exciting immunotherapeutic trial for multiple cancer subtypes. Article written by our senior research coordinator Karin Donaldson. Consider trials earlier in the course in patients with unresectable or metastatic cancer whenever possible. I have sponsor and IRB approval to place this article on this blog! More detail information can be found at MDNA and …
Imagine you’re driving your car when suddenly, it begins to malfunction – sputtering, stalling, and generally misbehaving. What’s going on under the hood? If you’re anything like most people, you’d probably take your car to a mechanic who can identify the faulty parts and get you back on the road. In many ways, oncologists can …
New article published in the NEJM confirming the high risk for gastric cancer with susceptible folks with H. Pylori infections. Another reason for me to check dna platforms such as 23andme! As a physician who not too long ago discovered my own asymptomatic H. pylori infection, I couldn’t help but wonder if there was more …
This post was written by our melanoma/sarcoma nurse navigator Ashlee Jones. She is highly respected by all members of my team to include the nurses, pharmacist, staff, research team, and physicians! I’ve always felt that new patients diagnosed with cancer can initially have a rough start in the journey given the new diagnosis, the array …
A recent publication by Dr Eroglu et al. in Cancer can be found here! Hope this articles helps! As an oncologist, my days are filled with fascinating and challenging cases, but one recent patient in particular caught my attention. He was a young man who had just undergone surgery to remove high-risk Stage IIC malignant …
Often I am asked about clinical trial options at our site or perhaps at other institutions. It is important for patients and families that they consider clinical trials at any point in their treatment journey. For most medical oncologist, it is preferred to consider a trial option if one is available to them and the …
Iovance recently announced their completion of the BLA to the FDA for Lifeleucel in Metastatic Melanoma. See press release here. Data for this study published in JCO here! This is a treatment protocol that we at the Orlando Health Cancer Institute have been very proud to have enroll and treat melanoma folks as well other …